EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of a low-cost, direct-current-based biosensor for real-time monitoring of transendothelial electrical resistance in cell barriers

Guo-Zhen Wang, Xiao-Nan Hou, Duo Tang, Tie Zhang iD, Zhi-Xiang Zhou

Biointerphases · 01.05.2026 · 21 (3)

DOI: 10.1116/6.0005440 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Biointerphases, online erschienen am 09.06.2026. Verfasst von Guo-Zhen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, China-Japan Friendship Hospital, Beijing 100029, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Electric Impedance, Endothelial Cells. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Municipal Chaoyang District Science and Technology Program FUND.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Real-time monitoring of biological barrier integrity is crucial for drug development and disease modeling. The gold-standard technique, transendothelial electrical resistance (TEER), is often limited by the cost and complexity of commercial alternating current systems. To address this, we developed a novel, low-cost biosensor based on a direct current (DC) series voltage division principle, featuring custom hardware and open-source firmware. Validation demonstrated a wide dynamic range (155–105 600 Ω cm2) and high accuracy (±3%). The device showed excellent correlation with a commercial EVOM3 system in monitoring TEER trends during endothelial barrier formation and oxidative stress-induced disruption. Biosensor readings were consistent with barrier kinetics captured by xCelligence RTCA and live-cell imaging. Furthermore, a strong negative correlation was established between decreasing TEER values and increasing paracellular leakage of sodium fluorescein. These results collectively validate our DC-based system as a reliable, accurate, and accessible tool for quantifying in vitro barrier integrity, with significant potential to democratize research in biomedicine and toxicology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesElectric ImpedanceEndothelial CellsHumansAnimals

Autor:innen und Institutionen

  • Clinical Laboratory, China-Japan Friendship Hospital, Beijing 100029, China.
  • The Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.
  • China Meat Research Center, Beijing Academy of Food Science, Beijing 100068, China.

ORCID-Profile: Tie Zhang

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Chaoyang District Science and Technology Program FUND

Zitieren

APA

Wang, G. Z., Hou, X. N., Tang, D., Zhang, T., & Zhou, Z. X. (2026). Development and validation of a low-cost, direct-current-based biosensor for real-time monitoring of transendothelial electrical resistance in cell barriers. Biointerphases, 21(3). https://doi.org/10.1116/6.0005440

Vancouver

Wang GZ, Hou XN, Tang D, Zhang T, Zhou ZX. Development and validation of a low-cost, direct-current-based biosensor for real-time monitoring of transendothelial electrical resistance in cell barriers. Biointerphases. 2026;21(3). doi:10.1116/6.0005440

BibTeX
@article{Wang2026,
  author = {Wang, Guo-Zhen and Hou, Xiao-Nan and Tang, Duo and Zhang, Tie and Zhou, Zhi-Xiang},
  title = {Development and validation of a low-cost, direct-current-based biosensor for real-time monitoring of transendothelial electrical resistance in cell barriers},
  journal = {Biointerphases},
  year = {2026},
  volume = {21},
  number = {3},
  doi = {10.1116/6.0005440}
}
Kostenlos starten →